Rybrevant Faspro (AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT))

**Product type:** Human Prescription Drug

**Active ingredient:** AMIVANTAMAB; HYALURONIDASE (HUMAN RECOMBINANT)

**Strength:** 2240; 28000 mg/14mL; mg/14mL

**Dosage form:** Injection

**Route:** Subcutaneous

**Labeler:** Janssen Biotech, Inc.

**Marketing category:** BLA (BLA761433)

**Pharmacologic class:** Endoglycosidase [EPC], Glycoside Hydrolases [CS]